Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Apr 2, 2018
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2018 PForm 4 → | Apr 2, 1:02 pm EDT | EyePoint Pharmaceuticals, Inc.PSDV | EW Healthcare Partners, L.P. +310% Owner | 8,606,324 | $1.10 | $9,466,956 | 8,606,324 | — | plan? |
| Mar 28, 2018 PForm 4 → | Mar 30, 4:28 pm EDT | OncoCyte CorpOCX | BROADWOOD PARTNERS, L.P. +210% Owner | 3,968,254 | $1.26 | $5,000,000 | 7,564,934 | +110% | plan? |
| Mar 28, 2018 PForm 4 → | Mar 29, 4:06 pm EDT | INTERNATIONAL TOWER HILL MINES LTDTHM | Electrum Strategic Opportunities Fund II L.P. +310% Owner | 6,676,852 | $0.50 | $3,338,426 | 26,571,380 | +33.6% | plan? |
| Mar 29, 2018 PForm 4 → | Apr 2, 3:56 pm EDT | Citius Pharmaceuticals, Inc.CTXR | Leonard L MazurExecutive Chairman, Director, 10% Owner | 167,504 | $2.99 | $499,999 | 3,718,340 | +4.72% | plan? |
| Dec 24, 2014 PForm 4 → | Mar 29, 2018, 4:47 pm EDT | FENNEC PHARMACEUTICALS INC.FENC | MANCHESTER MANAGEMENT CO LLC +310% Owner | 189,800 | $2.51 | $475,668 | 1,419,694 | +15.4% | plan? late |
| Jan 27, 2016 PForm 4 → | Mar 29, 2018, 4:59 pm EDT | FENNEC PHARMACEUTICALS INC.FENC | MANCHESTER MANAGEMENT PR, LLC +410% Owner | 190,850 | $2.06 | $392,528 | 1,586,899 | +13.7% | plan? late |
| Mar 30, 2018 PForm 4 → | Mar 30, 5:00 pm EDT | DOCUMENT SECURITY SYSTEMS INCDSS | Joseph L. SandersDirector | 400,000 | $0.75 | $300,000 | 650,033 | +160% | plan? |
| Mar 28, 2018 PForm 4 → | Mar 29, 9:39 pm EDT | Cogint, Inc.COGT | Ryan SchulkeChief Executive Officer, Director, 10% Owner | 100,000 | $2.58 | $258,000 | 6,264,537 | +1.62% | plan? |
| Mar 29, 2018 PForm 4 → | Apr 2, 6:53 am EDT | Cogint, Inc.COGT | Ryan SchulkeChief Executive Officer, Director, 10% Owner | 100,000 | $2.54 | $254,000 | 6,364,537 | +1.60% | plan? |
| Mar 29, 2018 PForm 4 → | Mar 29, 4:21 pm EDT | EMERGENT CAPITAL, INC.EMGC | Patrick J Curry +1CEO, Director, 10% Owner | 552,431 | $0.425 | $234,783 | 552,431 | — | plan? |
| Aug 29, 2014 PForm 4 → | Mar 29, 2018, 4:45 pm EDT | FENNEC PHARMACEUTICALS INC.FENC | MANCHESTER MANAGEMENT CO LLC +310% Owner | 82,666 | $2.48 | $205,132 | 1,324,794 | +6.66% | plan? late |
| Aug 23, 2016 PForm 4 → | Mar 29, 2018, 5:03 pm EDT | FENNEC PHARMACEUTICALS INC.FENC | MANCHESTER MANAGEMENT PR, LLC +410% Owner | 96,000 | $2.01 | $192,640 | 1,634,899 | +6.24% | plan? late |
| May 27, 2015 PForm 4 → | Mar 29, 2018, 4:48 pm EDT | FENNEC PHARMACEUTICALS INC.FENC | MANCHESTER MANAGEMENT CO LLC +310% Owner | 102,960 | $1.65 | $170,046 | 1,471,174 | +7.53% | plan? late |
| Mar 29, 2018 PForm 4 → | Apr 2, 2:37 pm EDT | CREDIT SUISSE ASSET MANAGEMENT INCOME FUND INCCIK | CSAM Americas Holding Corp.Other | 32,517 | $3.22 | $104,584 | 349,389 | +10.3% | plan? |
| Mar 28, 2018 PForm 4 → | Mar 29, 9:38 pm EDT | Cogint, Inc.COGT | Matthew ConlinPresident, Director, 10% Owner | 40,000 | $2.54 | $101,579 | 4,411,080 | +0.92% | plan? |
| Mar 29, 2018 PForm 4 → | Mar 29, 4:16 pm EDT | EMERGENT CAPITAL, INC.EMGC | Roy PattersonDirector | 236,000 | $0.425 | $100,300 | 498,198 | +90.0% | plan? |
| Mar 27, 2018 PForm 4 → | Mar 29, 7:21 pm EDT | Revolution Lighting Technologies, Inc.RVLT | Robert V LapentaChairman and CEO, Director, 10% Owner | 26,476 | $3.46 | $91,607 | 1,001,476 | +2.72% | plan? |
| Mar 27, 2018 PForm 4 → | Mar 29, 4:52 pm EDT | LEGACY RESERVES LPLGCY | Baines Creek Capital, LLC10% Owner | 18,271 | $4.75 | $86,814 | 13,591,698 | +0.13% | plan? |
| Mar 29, 2018 PForm 4 → | Apr 2, 2:33 pm EDT | CCUR Holdings, Inc.CCUR | Julian D. Singer10% Owner | 15,800 | $4.80 | $75,837 | 2,665,468 | +0.60% | plan? |
| Dec 29, 2015 PForm 4 → | Mar 29, 2018, 4:51 pm EDT | FENNEC PHARMACEUTICALS INC.FENC | MANCHESTER MANAGEMENT CO LLC +310% Owner | 40,600 | $1.78 | $72,304 | 1,491,474 | +2.80% | plan? late |
| Jul 26, 2016 PForm 5 → | Apr 2, 2018, 11:54 am EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 342,000 | $0.1246 | $42,618 | 8,676,492 | +4.10% | plan? |
| Mar 27, 2018 PForm 4 → | Mar 29, 7:13 pm EDT | ROYAL HAWAIIAN ORCHARDS, L.P.NNUTU | Farhad Fred Ebrahimi10% Owner | 15,194 | $2.26 | $34,372 | 11,000 | — | plan? |
| Jun 17, 2016 PForm 5 → | Apr 2, 2018, 11:10 am EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 195,500 | $0.1717 | $33,569 | 8,676,492 | +2.31% | plan? |
| Apr 1, 2018 PForm 4 → | Apr 2, 12:19 pm EDT | LAKE AREA CORN PROCESSORS LLCno symbol | Rick Alan KaspersonDirector | 10,000 | $3.30 | $33,000 | 100,000 | +11.1% | plan? |
| Mar 29, 2018 PForm 4 → | Mar 30, 8:11 am EDT | LADENBURG THALMANN FINANCIAL SERVICES INC.LTS | Richard LampenPresident and CEO, Director | 10,000 | $3.30 | $32,957 | 2,300,059 | +0.44% | plan? |
| Mar 16, 2016 PForm 5 → | Mar 30, 2018, 2:59 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 201,300 | $0.1575 | $31,704 | 20,800,359 | +0.98% | plan? |
| Mar 29, 2018 PForm 4 → | Apr 2, 11:38 am EDT | ACORN ENERGY, INC.ACFN | Jan H LoebPresident and CEO, Director | 105,000 | $0.30 | $31,498 | 1,288,174 | +8.87% | plan? |
| Aug 17, 2016 PForm 5 → | Apr 2, 2018, 12:52 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 287,900 | $0.1084 | $31,200 | 8,676,492 | +3.43% | plan? |
| Sep 21, 2016 PForm 5 → | Apr 2, 2018, 2:21 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 377,500 | $0.0817 | $30,837 | 8,676,492 | +4.55% | plan? |
| Oct 26, 2016 PForm 5 → | Apr 2, 2018, 3:07 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 394,000 | $0.0661 | $26,034 | 12,949,027 | +3.14% | plan? |
| Sep 2, 2016 PForm 5 → | Apr 2, 2018, 1:35 pm EDT | Immune Therapeutics, Inc.IMUN | Richard GostanianOther | 243,747 | $0.1052 | $25,648 | 8,676,492 | +2.89% | plan? |
| Mar 1, 2016 PForm 5 → | Mar 30, 2018, 2:41 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 133,650 | $0.1698 | $22,689 | 20,800,359 | +0.65% | plan? |
| Sep 27, 2016 PForm 5 → | Mar 30, 2018, 4:57 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 217,600 | $0.0821 | $17,875 | 20,800,359 | +1.06% | plan? |
| Mar 29, 2018 PForm 4 → | Mar 30, 6:47 pm EDT | Heritage Global Inc.HGBL | Scott Allen WestCFO, Heritage Global Inc. | 41,005 | $0.39 | $15,992 | 402,478 | +11.3% | plan? |
| Aug 15, 2016 PForm 5 → | Mar 30, 2018, 4:17 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 144,760 | $0.1085 | $15,700 | 20,800,359 | +0.70% | plan? |
| Mar 28, 2018 PForm 4 → | Mar 30, 4:30 pm EDT | REVA Medical, Inc.RVA.AX | Robert Bain ThomasDirector | 5,000 | $2.99 | $14,945 | 37,300 | +15.5% | plan? |
| May 4, 2016 PForm 5 → | Mar 30, 2018, 3:26 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 99,500 | $0.1416 | $14,088 | 20,800,359 | +0.48% | plan? |
| Jan 27, 2016 PForm 5 → | Mar 30, 2018, 2:28 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 80,050 | $0.172 | $13,769 | 20,800,359 | +0.39% | plan? |
| Mar 28, 2018 PForm 4 → | Mar 29, 6:07 pm EDT | U.S. GOLD CORP.USAU | David C. MathewsonVice President of Exploration | 10,000 | $1.27 | $12,700 | 420,624 | +2.44% | plan? |
| Jan 5, 2016 PForm 5 → | Mar 29, 2018, 8:34 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 64,600 | $0.1943 | $12,551 | 20,800,359 | +0.31% | plan? |
| Mar 28, 2018 PForm 4 → | Mar 30, 4:25 pm EDT | WIDEPOINT CORPWYY | Jin KangCEO, Director | 20,000 | $0.555 | $11,100 | 2,950,344 | +0.68% | plan? |
| Jun 14, 2016 PForm 5 → | Mar 30, 2018, 3:45 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 58,100 | $0.1732 | $10,062 | 20,800,359 | +0.28% | plan? |
| Mar 24, 2016 PForm 5 → | Mar 30, 2018, 3:12 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 59,600 | $0.1595 | $9,504 | 20,800,359 | +0.29% | plan? |
| Jan 4, 2016 PForm 5 → | Mar 29, 2018, 8:20 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 530,000 | $0.0171 | $9,070 | 20,800,359 | +2.61% | plan? |
| Mar 28, 2018 PForm 4 → | Mar 29, 6:00 pm EDT | Citius Pharmaceuticals, Inc.CTXR | Myron Z HolubiakPresident and CEO, Director | 2,915 | $3.09 | $9,007 | 519,882 | +0.56% | plan? |
| Jun 17, 2016 PForm 5 → | Mar 30, 2018, 4:02 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 55,500 | $0.1516 | $8,413 | 20,800,359 | +0.27% | plan? |
| Mar 29, 2018 PForm 4 → | Apr 2, 8:10 am EDT | SCYNEXIS INCSCYX | Gonzalez David AnguloChief Medical Officer | 6,000 | $1.36 | $8,160 | 101,790 | +6.26% | plan? |
| Mar 30, 2018 PForm 4 → | Mar 30, 2:19 pm EDT | ARC DOCUMENT SOLUTIONS, INC.ARC | Dennis Jeffery GrimesVP, Sr. Counsel & Corp Secty | 4,360 | $1.87 | $8,153 | 43,593 | +11.1% | plan? |
| Sep 12, 2017 PForm 5 → | Mar 29, 2018, 7:48 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 336,000 | $0.0227 | $7,620 | 22,059,859 | +1.55% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 2, 3:22 pm EDT | KINGSWAY FINANCIAL SERVICES INCKFS | Larry G Swets Jr.CEO, Director | 530 | $3.93 | $2,084 | 2,091,968 | +0.03% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 2, 3:35 pm EDT | KINGSWAY FINANCIAL SERVICES INCKFS | John Taylor Maloney FitzgeraldPresident and COO, Director | 424 | $3.93 | $1,667 | 871,189 | +0.05% | plan? |
| Mar 28, 2018 PForm 4 → | Mar 30, 6:30 pm EDT | AMARILLO BIOSCIENCES INCAMAR | Stephen T ChenPresident, CEO & Chairman, Director, 10% Owner | 8,000 | $0.1969 | $1,575 | 297,716 | +2.76% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 2, 3:14 pm EDT | KINGSWAY FINANCIAL SERVICES INCKFS | William August Hickey Jr.CFO and EVP | 382 | $3.93 | $1,502 | 305,592 | +0.13% | plan? |
| Apr 2, 2018 PForm 4 → | Apr 2, 3:08 pm EDT | KINGSWAY FINANCIAL SERVICES INCKFS | Hassan BaqarVice President | 254 | $3.93 | $999 | 153,536 | +0.17% | plan? |
| Nov 28, 2016 PForm 5 → | Mar 30, 2018, 5:03 pm EDT | Immune Therapeutics, Inc.IMUN | Robert Jackman DaileyOther | 12,300 | $0.0809 | $995 | 20,800,359 | +0.06% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.